A failing digital portfolio was stabilized in 30 days and transformed into a scalable, high-performance platform—cutting $1M in operating costs within six months.

A pharmaceutical commercialization company transformed a stalled acquisition into a strategic asset—cutting 90% of operating costs and securing their first major customer post-integration.

A pharmaceutical manufacturer launching a rare disease therapy overcame tangled systems, shifting requirements, and an FDA REMS mandate with a digitally enabled patient support experience delivered on time and on budget.